Microvessels support engraftment and functionality of human islets and hESC-derived pancreatic progenitors in diabetes models
Islet transplantation is a promising treatment for type 1 diabetes (T1D), yet the low donor pool, poor islet engraftment, and life-long immunosuppression prevent it from becoming the standard of care. Human embryonic stem cell (hESC)-derived pancreatic cells could eliminate donor shortages, but inte...
Saved in:
Published in | Cell stem cell Vol. 28; no. 11; pp. 1936 - 1949.e8 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
04.11.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Islet transplantation is a promising treatment for type 1 diabetes (T1D), yet the low donor pool, poor islet engraftment, and life-long immunosuppression prevent it from becoming the standard of care. Human embryonic stem cell (hESC)-derived pancreatic cells could eliminate donor shortages, but interventions to improve graft survival are needed. Here, we enhanced subcutaneous engraftment by employing a unique vascularization strategy based on ready-made microvessels (MVs) isolated from the adipose tissue. This resulted in improved cell survival and effective glucose response of both human islets and hESC-derived pancreatic cells, which ameliorated preexisting diabetes in three mouse models of T1D.
[Display omitted]
•Microvessels support engraftment of pancreatic cells in the subcutaneous site•Transplantation of microvessels with pancreatic cells accelerates diabetes reversal•Microvessels enable diabetes reversal with a subtherapeutic dose of human islets•Microvessels replenish the intraislet vasculature of the transplanted human islets
Aghazadeh et al. show that transplantation of adipose-derived microvessels in the subcutaneous space supports early connection to the host vasculature, promoting engraftment and function of either hESC-derived pancreatic progenitors or human islets. This strategy resulted in improved graft survival and effective glucose response, leading to accelerated reversal of diabetes. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1934-5909 1875-9777 |
DOI: | 10.1016/j.stem.2021.08.001 |